Spectrum Pharmaceuticals, Inc. (SPPI) Launches a Broad-based FUSILEV® Marketing Campaign; Increases Sales Force Footprint
8/15/2012 10:11:13 AM
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with a primary focus in oncology and hematology, today announced the launch of the Company’s broad-based FUSILEV (levoleucovorin) marketing campaign directed towards oncologists, nurses, office practice managers and pharmacists. The recently launched campaign features a new FUSILEV.com website, health care professional educational tools and resources, digital and online campaign, and peer-to-peer live educational programs.
comments powered by